Overview

Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

Status:
Completed

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

To assess drug drug interaction through pharmacokinetics investigation at steady state of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) given as three different formulations in healthy Japanese male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Amlodipine
Hydrochlorothiazide
Telmisartan
Telmisartan amlodipine combination